BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9198138)

  • 21. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
    J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor: an enzyme cofactor and a true receptor.
    Morrissey JH
    Thromb Haemost; 2001 Jul; 86(1):66-74. PubMed ID: 11487043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
    Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Rapundalo ST; Saiya-Cork K; Leadley RJ; Narasimhan L; Zhang E; Whitlow M; Adler M; McLean K; Chou YL; McKnight C; Arnaiz DO; Shaw KJ; Light DR; Edmunds JJ
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4752-6. PubMed ID: 16125385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue factor on cells.
    Rao LV; Pendurthi UR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S27-35. PubMed ID: 9819026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of Factor VIIa/tissue factor.
    Shirk RA; Vlasuk GP
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-Eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2005 Jan; 326(4):859-65. PubMed ID: 15607748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
    Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Narasimhan LS; Zhang E; Rapundalo ST; Saiya-Cork K; Leadley RJ; Edmunds JJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1060-4. PubMed ID: 16289811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of tissue factor and its inhibitor in hemostasis].
    Naumnik B; Małyszko J; Myśliwiec M
    Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
    Olsen OH; Nielsen PF; Persson E
    Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.
    Kotian PL; Krishnan R; Rowland S; El-Kattan Y; Saini SK; Upshaw R; Bantia S; Arnold S; Babu YS; Chand P
    Bioorg Med Chem; 2009 Jun; 17(11):3934-58. PubMed ID: 19409795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins.
    Lee GF; Lazarus RA; Kelley RF
    Biochemistry; 1997 May; 36(19):5607-11. PubMed ID: 9153400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
    Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
    Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity.
    Neuenschwander PF; Branam DE; Morrissey JH
    Thromb Haemost; 1993 Dec; 70(6):970-7. PubMed ID: 8165620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor-factor VIIa signaling.
    Rao LV; Pendurthi UR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):47-56. PubMed ID: 15569823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.